Trio-Tech International (NYSE:TRT) Earns Buy Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of Trio-Tech International (NYSE:TRTFree Report) in a report released on Monday. The firm issued a buy rating on the stock.

Trio-Tech International Trading Up 1.3 %

Shares of NYSE:TRT opened at $6.01 on Monday. The company has a quick ratio of 3.64, a current ratio of 3.99 and a debt-to-equity ratio of 0.02. Trio-Tech International has a 12 month low of $4.94 and a 12 month high of $7.88. The company’s fifty day simple moving average is $6.49 and its 200 day simple moving average is $6.13. The firm has a market cap of $25.54 million, a price-to-earnings ratio of 42.93 and a beta of 1.06.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Trio-Tech International stock. Empowered Funds LLC raised its holdings in Trio-Tech International (NYSE:TRTFree Report) by 5.3% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 34,478 shares of the company’s stock after purchasing an additional 1,742 shares during the period. Empowered Funds LLC owned approximately 0.81% of Trio-Tech International worth $191,000 at the end of the most recent quarter. Institutional investors own 16.03% of the company’s stock.

About Trio-Tech International

(Get Free Report)

Trio-Tech International, together with its subsidiaries, offers manufacturing, testing, and distribution services to the semiconductor industry. It operates through four segments: Manufacturing, Testing Services, Distribution, and Real Estate. The company develops and manufactures test equipment used in front-end and back-end manufacturing processes of semiconductors.

Read More

Receive News & Ratings for Trio-Tech International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trio-Tech International and related companies with MarketBeat.com's FREE daily email newsletter.